We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.1B
AUM Growth
+$362M
Cap. Flow
-$1.11B
Cap. Flow %
-3.25%
Top 10 Hldgs %
15.48%
Holding
3,181
New
192
Increased
947
Reduced
1,799
Closed
170

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63.9M
2
MSFT icon
Microsoft
MSFT
+$31.4M
3
IBM icon
IBM
IBM
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$23M
5
PFE icon
Pfizer
PFE
+$18.3M

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 14.25%
3 Healthcare 13.21%
4 Industrials 11.1%
5 Energy 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RM icon
2876
Regional Management Corp
RM
$301M
$177K ﹤0.01%
+11,425
New +$196K
ENVE
2877
DELISTED
ENVENTIS CORP COM STK
ENVE
$177K ﹤0.01%
11,196
-10
-0.1% -$128
TGTX icon
2878
TG Therapeutics
TGTX
$7.96B
$176K ﹤0.01%
18,714
+8,088
+76% +$51.7K
CASC
2879
DELISTED
Cascadian Therapeutics, Inc.
CASC
$176K ﹤0.01%
+9,068
New +$160K
AGEN
2880
Agenus
AGEN
$312M
$175K ﹤0.01%
+2,777
New +$161K
BBBY
2881
Bed Bath & Beyond
BBBY
$481M
$174K ﹤0.01%
14,657
-86
-0.6% -$1.06K
CSCD
2882
DELISTED
CASCADE MICROTECH, INC.
CSCD
$174K ﹤0.01%
+12,730
New +$142K
ESCA icon
2883
Escalade
ESCA
$273M
$173K ﹤0.01%
+10,705
New +$163K
HCKT icon
2884
Hackett Group
HCKT
$270M
$173K ﹤0.01%
28,920
+317
+1% +$1.91K
TSYS
2885
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$173K ﹤0.01%
52,677
+1,580
+3% +$4.65K
HRTX icon
2886
Heron Therapeutics
HRTX
$93.9M
$172K ﹤0.01%
+13,950
New +$167K
POZN
2887
DELISTED
POZEN INC
POZN
$172K ﹤0.01%
20,670
-12,910
-38% -$111K
BEAT
2888
DELISTED
BioTelemetry, Inc.
BEAT
$172K ﹤0.01%
+23,990
New +$191K
TNAV
2889
DELISTED
Telenav Inc.
TNAV
$171K ﹤0.01%
29,973
+8,218
+38% +$48.4K
NOR
2890
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$171K ﹤0.01%
6,903
+982
+17% +$24.5K
CWST icon
2891
Casella Waste Systems
CWST
$5.71B
$170K ﹤0.01%
33,972
+850
+3% +$4.46K
PALI icon
2892
Palisade Bio
PALI
$330M
0
MTEM
2893
DELISTED
Molecular Templates, Inc.
MTEM
$169K ﹤0.01%
259
+19
+8% +$12.6K
PBPB
2894
DELISTED
Potbelly
PBPB
$168K ﹤0.01%
+10,540
New +$172K
APAGF
2895
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
$168K ﹤0.01%
11,643
+129
+1% +$1.86K
AMRC icon
2896
Ameresco
AMRC
$1.12B
$166K ﹤0.01%
23,596
-470
-2% -$3.18K
ARX
2897
DELISTED
Aeroflex Holding Corp (DE)
ARX
$166K ﹤0.01%
15,814
-8,670
-35% -$80.1K
EPM icon
2898
Evolution Petroleum
EPM
$132M
$165K ﹤0.01%
15,045
+320
+2% +$3.67K
CEMP
2899
DELISTED
Cempra, Inc.
CEMP
$165K ﹤0.01%
15,375
+1,852
+14% +$17.9K
ACW
2900
DELISTED
Accuride Corp
ACW
$165K ﹤0.01%
33,791
-4,740
-12% -$24.2K

Similar funds

RhumbLine Advisers's Q2 2014 Portfolio in Review

As of Q2 2014, RhumbLine Advisers held 3,181 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.11B in Q2 2014, closing 170 positions and reducing 1,799 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Navient worth $10M.

  • RhumbLine Advisers's largest Q2 2014 buy was Navient: 566,289 shares worth $10M.
  • RhumbLine Advisers added most to American Airlines Group in Q2 2014, an estimated $22.1M increase.
  • RhumbLine Advisers's biggest Q2 2014 reduction was Apple, cutting an estimated $63.9M.
  • RhumbLine Advisers fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $18.3M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $34.1B portfolio in Q2 2014.
  • RhumbLine Advisers opened 192 new positions and closed 170 in Q2 2014.
  • RhumbLine Advisers's portfolio value rose 1.1% quarter-over-quarter to $34.1B.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.